Tenon Medical, Inc. (NASDAQ: TNON) Stock Competitors & Peer Comparison
See TNON's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TNON and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TNON | $5.93 | +11.89% | 2.9M | -0.13 | -$44.87 | N/A |
| ABT | $101.95 | -1.36% | 176.4B | 19.57 | $5.21 | +2.43% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $90.96 | -0.72% | 116.5B | 16.45 | $5.53 | +3.14% |
| SYK | $275.56 | +2.06% | 105.6B | 20.58 | $13.39 | +1.27% |
| BSX | $42.98 | -0.28% | 63.9B | 13.86 | $3.10 | N/A |
| EW | $84.37 | -2.77% | 48.6B | 31.26 | $2.70 | N/A |
| DXCM | $83.03 | -1.75% | 31.3B | 32.56 | $2.55 | N/A |
| GEHC | $63.93 | -0.48% | 28.9B | 14.02 | $4.56 | +0.22% |
| PHG | $24.59 | -0.04% | 24B | 14.06 | $1.75 | +4.03% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
TNON vs ABT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ABT has a market cap of 176.4B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ABT trades at $101.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ABT's P/E ratio is 19.57. In terms of profitability, TNON's ROE is -5.47%, compared to ABT's ROE of +0.11%. Regarding short-term risk, TNON is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
TNON vs BSX-PA Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, TNON's ROE is -5.47%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, TNON is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
TNON vs MDT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, MDT has a market cap of 116.5B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while MDT trades at $90.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas MDT's P/E ratio is 16.45. In terms of profitability, TNON's ROE is -5.47%, compared to MDT's ROE of +0.11%. Regarding short-term risk, TNON is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
TNON vs SYK Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SYK has a market cap of 105.6B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SYK trades at $275.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SYK's P/E ratio is 20.58. In terms of profitability, TNON's ROE is -5.47%, compared to SYK's ROE of +0.16%. Regarding short-term risk, TNON is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
TNON vs BSX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BSX has a market cap of 63.9B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BSX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BSX's P/E ratio is 13.86. In terms of profitability, TNON's ROE is -5.47%, compared to BSX's ROE of +0.15%. Regarding short-term risk, TNON is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
TNON vs EW Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, EW has a market cap of 48.6B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while EW trades at $84.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas EW's P/E ratio is 31.26. In terms of profitability, TNON's ROE is -5.47%, compared to EW's ROE of +0.10%. Regarding short-term risk, TNON is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for TNON.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
TNON vs DXCM Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, DXCM has a market cap of 31.3B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while DXCM trades at $83.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas DXCM's P/E ratio is 32.56. In terms of profitability, TNON's ROE is -5.47%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, TNON is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for TNON.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
TNON vs GEHC Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, GEHC has a market cap of 28.9B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while GEHC trades at $63.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas GEHC's P/E ratio is 14.02. In terms of profitability, TNON's ROE is -5.47%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, TNON is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for TNON.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
TNON vs PHG Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, PHG has a market cap of 24B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while PHG trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas PHG's P/E ratio is 14.06. In terms of profitability, TNON's ROE is -5.47%, compared to PHG's ROE of +0.10%. Regarding short-term risk, TNON is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for TNON.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
TNON vs ZBH Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ZBH has a market cap of 18.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ZBH trades at $93.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ZBH's P/E ratio is 11.02. In terms of profitability, TNON's ROE is -5.47%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, TNON is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
TNON vs ABMD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ABMD's P/E ratio is 65.36. In terms of profitability, TNON's ROE is -5.47%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, TNON is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
TNON vs SWAV Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SWAV's P/E ratio is 78.76. In terms of profitability, TNON's ROE is -5.47%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, TNON is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
TNON vs PEN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while PEN trades at $317.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas PEN's P/E ratio is 82.97. In terms of profitability, TNON's ROE is -5.47%, compared to PEN's ROE of +0.11%. Regarding short-term risk, TNON is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
TNON vs SNN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SNN has a market cap of 11.5B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SNN trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SNN's P/E ratio is 12.93. In terms of profitability, TNON's ROE is -5.47%, compared to SNN's ROE of +0.12%. Regarding short-term risk, TNON is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
TNON vs ALGN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ALGN has a market cap of 10.8B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ALGN trades at $150.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ALGN's P/E ratio is 13.75. In terms of profitability, TNON's ROE is -5.47%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, TNON is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
TNON vs GMED Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, GMED has a market cap of 10B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while GMED trades at $74.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas GMED's P/E ratio is 16.71. In terms of profitability, TNON's ROE is -5.47%, compared to GMED's ROE of +0.12%. Regarding short-term risk, TNON is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for TNON.Check GMED's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
TNON vs BIO-B Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BIO-B has a market cap of 10B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BIO-B trades at $365.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BIO-B's P/E ratio is -64.28. In terms of profitability, TNON's ROE is -5.47%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, TNON is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
TNON vs BIO Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BIO has a market cap of 9.9B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BIO trades at $369.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BIO's P/E ratio is 39.76. In terms of profitability, TNON's ROE is -5.47%, compared to BIO's ROE of +0.03%. Regarding short-term risk, TNON is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BIO's competition here
Glaukos Corporation (NYSE: GKOS)
TNON vs GKOS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, GKOS has a market cap of 9.9B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while GKOS trades at $167.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas GKOS's P/E ratio is -194.59. In terms of profitability, TNON's ROE is -5.47%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, TNON is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check GKOS's competition here
Masimo Corporation (NASDAQ: MASI)
TNON vs MASI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas MASI's P/E ratio is 44.43. In terms of profitability, TNON's ROE is -5.47%, compared to MASI's ROE of +0.09%. Regarding short-term risk, TNON is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check MASI's competition here
Insulet Corp. (NASDAQ: PODD)
TNON vs PODD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, PODD has a market cap of 9.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while PODD trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas PODD's P/E ratio is 22.48. In terms of profitability, TNON's ROE is -5.47%, compared to PODD's ROE of +0.27%. Regarding short-term risk, TNON is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check PODD's competition here
Bruker Corporation (NASDAQ: BRKR)
TNON vs BRKR Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BRKR trades at $53.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BRKR's P/E ratio is 26.85. In terms of profitability, TNON's ROE is -5.47%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, TNON is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
TNON vs BRKRP Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BRKRP has a market cap of 8B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BRKRP trades at $399.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BRKRP's P/E ratio is 216.13. In terms of profitability, TNON's ROE is -5.47%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, TNON is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
TNON vs NARI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas NARI's P/E ratio is -59.24. In terms of profitability, TNON's ROE is -5.47%, compared to NARI's ROE of -0.00%. Regarding short-term risk, TNON is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
TNON vs HAE Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while HAE trades at $102.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas HAE's P/E ratio is 20.50. In terms of profitability, TNON's ROE is -5.47%, compared to HAE's ROE of +0.11%. Regarding short-term risk, TNON is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for TNON.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
TNON vs LIVN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while LIVN trades at $78.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas LIVN's P/E ratio is 18.57. In terms of profitability, TNON's ROE is -5.47%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, TNON is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
TNON vs ITGR Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ITGR trades at $126.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ITGR's P/E ratio is 19.84. In terms of profitability, TNON's ROE is -5.47%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, TNON is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
TNON vs IRTC Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while IRTC trades at $111.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas IRTC's P/E ratio is -259.14. In terms of profitability, TNON's ROE is -5.47%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, TNON is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for TNON.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
TNON vs AXNX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas AXNX's P/E ratio is -709.80. In terms of profitability, TNON's ROE is -5.47%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, TNON is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
TNON vs TMDX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, TMDX has a market cap of 2.8B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while TMDX trades at $82.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas TMDX's P/E ratio is 41.72. In terms of profitability, TNON's ROE is -5.47%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, TNON is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
TNON vs NEOG Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while NEOG trades at $11.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas NEOG's P/E ratio is 42.07. In terms of profitability, TNON's ROE is -5.47%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, TNON is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for TNON.Check NEOG's competition here
AxoGen, Inc. (NASDAQ: AXGN)
TNON vs AXGN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while AXGN trades at $42.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas AXGN's P/E ratio is 110.95. In terms of profitability, TNON's ROE is -5.47%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, TNON is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
TNON vs UFPT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while UFPT trades at $277.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas UFPT's P/E ratio is 28.39. In terms of profitability, TNON's ROE is -5.47%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, TNON is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check UFPT's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
TNON vs INSP Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, INSP has a market cap of 2.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while INSP trades at $73.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas INSP's P/E ratio is 32.18. In terms of profitability, TNON's ROE is -5.47%, compared to INSP's ROE of +0.18%. Regarding short-term risk, TNON is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for TNON.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
TNON vs ESTA Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ESTA trades at $70.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ESTA's P/E ratio is -56.30. In terms of profitability, TNON's ROE is -5.47%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, TNON is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
TNON vs NUVA Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas NUVA's P/E ratio is 75.00. In terms of profitability, TNON's ROE is -5.47%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, TNON is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for TNON.Check NUVA's competition here
Butterfly Network, Inc. (NYSE: BFLY)
TNON vs BFLY Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BFLY has a market cap of 1.9B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BFLY trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BFLY's P/E ratio is -30.48. In terms of profitability, TNON's ROE is -5.47%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, TNON is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BFLY's competition here
Novocure Ltd (NASDAQ: NVCR)
TNON vs NVCR Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while NVCR trades at $15.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas NVCR's P/E ratio is -11.93. In terms of profitability, TNON's ROE is -5.47%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, TNON is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for TNON.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
TNON vs ATEC Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ATEC trades at $10.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ATEC's P/E ratio is -176.33. In terms of profitability, TNON's ROE is -5.47%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, TNON is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
TNON vs CNMD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CNMD trades at $46.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CNMD's P/E ratio is 10.19. In terms of profitability, TNON's ROE is -5.47%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, TNON is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
TNON vs HSKA Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas HSKA's P/E ratio is -62.49. In terms of profitability, TNON's ROE is -5.47%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, TNON is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for TNON.Check HSKA's competition here
Artivion, Inc. (NYSE: AORT)
TNON vs AORT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while AORT trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas AORT's P/E ratio is 41.80. In terms of profitability, TNON's ROE is -5.47%, compared to AORT's ROE of -0.01%. Regarding short-term risk, TNON is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check AORT's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
TNON vs IART Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while IART trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas IART's P/E ratio is 6.57. In terms of profitability, TNON's ROE is -5.47%, compared to IART's ROE of -0.01%. Regarding short-term risk, TNON is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for TNON.Check IART's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
TNON vs TNDM Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while TNDM trades at $17.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas TNDM's P/E ratio is -18.40. In terms of profitability, TNON's ROE is -5.47%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, TNON is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for TNON.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
TNON vs AVNS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas AVNS's P/E ratio is 27.77. In terms of profitability, TNON's ROE is -5.47%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, TNON is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
TNON vs PRCT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while PRCT trades at $20.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas PRCT's P/E ratio is -10.51. In terms of profitability, TNON's ROE is -5.47%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, TNON is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
TNON vs SILK Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SILK's P/E ratio is -18.96. In terms of profitability, TNON's ROE is -5.47%, compared to SILK's ROE of -0.35%. Regarding short-term risk, TNON is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SILK's competition here
Enovis Corporation (NYSE: ENOV)
TNON vs ENOV Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ENOV trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ENOV's P/E ratio is 5.52. In terms of profitability, TNON's ROE is -5.47%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, TNON is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
TNON vs LMRI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while LMRI trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas LMRI's P/E ratio is -22.36. In terms of profitability, TNON's ROE is -5.47%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, TNON is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
TNON vs FNA Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas FNA's P/E ratio is -19.83. In terms of profitability, TNON's ROE is -5.47%, compared to FNA's ROE of -0.35%. Regarding short-term risk, TNON is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for TNON.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
TNON vs IRMD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while IRMD trades at $82.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas IRMD's P/E ratio is 41.32. In terms of profitability, TNON's ROE is -5.47%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, TNON is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check IRMD's competition here
CeriBell, Inc. (NASDAQ: CBLL)
TNON vs CBLL Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CBLL has a market cap of 896.6M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CBLL trades at $23.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CBLL's P/E ratio is -13.43. In terms of profitability, TNON's ROE is -5.47%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, TNON is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
TNON vs BVS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BVS has a market cap of 879.4M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BVS trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BVS's P/E ratio is 17.08. In terms of profitability, TNON's ROE is -5.47%, compared to BVS's ROE of +0.28%. Regarding short-term risk, TNON is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
TNON vs INMD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, INMD has a market cap of 856.5M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while INMD trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas INMD's P/E ratio is 10.35. In terms of profitability, TNON's ROE is -5.47%, compared to INMD's ROE of +0.12%. Regarding short-term risk, TNON is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
TNON vs CSII Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CSII's P/E ratio is -20.83. In terms of profitability, TNON's ROE is -5.47%, compared to CSII's ROE of -0.14%. Regarding short-term risk, TNON is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CSII's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
TNON vs AHCO Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, AHCO has a market cap of 824.5M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while AHCO trades at $6.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas AHCO's P/E ratio is 12.37. In terms of profitability, TNON's ROE is -5.47%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, TNON is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for TNON.Check AHCO's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
TNON vs SIBN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SIBN has a market cap of 815.1M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SIBN trades at $18.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SIBN's P/E ratio is -54.06. In terms of profitability, TNON's ROE is -5.47%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, TNON is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
TNON vs AVR Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, AVR has a market cap of 811.9M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while AVR trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas AVR's P/E ratio is -4.30. In terms of profitability, TNON's ROE is -5.47%, compared to AVR's ROE of -0.78%. Regarding short-term risk, TNON is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for TNON.Check AVR's competition here
Varex Imaging Corporation (NASDAQ: VREX)
TNON vs VREX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, VREX has a market cap of 777.2M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while VREX trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas VREX's P/E ratio is 19.43. In terms of profitability, TNON's ROE is -5.47%, compared to VREX's ROE of +0.05%. Regarding short-term risk, TNON is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check VREX's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
TNON vs BBNX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BBNX has a market cap of 745.5M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BBNX trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BBNX's P/E ratio is -10.04. In terms of profitability, TNON's ROE is -5.47%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, TNON is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BBNX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
TNON vs SSII Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SSII has a market cap of 662.4M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SSII trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SSII's P/E ratio is -64.56. In terms of profitability, TNON's ROE is -5.47%, compared to SSII's ROE of -0.27%. Regarding short-term risk, TNON is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
TNON vs SRDX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SRDX's P/E ratio is -34.66. In terms of profitability, TNON's ROE is -5.47%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, TNON is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
TNON vs CTKB Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CTKB has a market cap of 595.3M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CTKB trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CTKB's P/E ratio is -24.42. In terms of profitability, TNON's ROE is -5.47%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, TNON is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CTKB's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
TNON vs APEN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas APEN's P/E ratio is -9.43. In terms of profitability, TNON's ROE is -5.47%, compared to APEN's ROE of -0.85%. Regarding short-term risk, TNON is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
TNON vs KIDS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, KIDS has a market cap of 566.6M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while KIDS trades at $22.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas KIDS's P/E ratio is -18.69. In terms of profitability, TNON's ROE is -5.47%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, TNON is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
TNON vs DCTH Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, DCTH has a market cap of 549.2M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while DCTH trades at $15.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas DCTH's P/E ratio is 1591.00. In terms of profitability, TNON's ROE is -5.47%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, TNON is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for TNON.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
TNON vs ZIMV Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, TNON's ROE is -5.47%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, TNON is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
TNON vs TCMD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, TCMD has a market cap of 505.3M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while TCMD trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas TCMD's P/E ratio is 20.74. In terms of profitability, TNON's ROE is -5.47%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, TNON is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
TNON vs CERS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CERS has a market cap of 501.8M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CERS trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CERS's P/E ratio is -49.70. In terms of profitability, TNON's ROE is -5.47%, compared to CERS's ROE of -0.10%. Regarding short-term risk, TNON is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
TNON vs NPCE Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, NPCE has a market cap of 478.7M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while NPCE trades at $14.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas NPCE's P/E ratio is -24.63. In terms of profitability, TNON's ROE is -5.47%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, TNON is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for TNON.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
TNON vs SGHT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SGHT has a market cap of 442.9M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SGHT trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SGHT's P/E ratio is -14.54. In terms of profitability, TNON's ROE is -5.47%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, TNON is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SGHT's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
TNON vs CLPT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CLPT has a market cap of 411.5M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CLPT trades at $13.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CLPT's P/E ratio is -11.63. In terms of profitability, TNON's ROE is -5.47%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, TNON is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
TNON vs PACB Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, PACB has a market cap of 403.8M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while PACB trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas PACB's P/E ratio is -3.17. In terms of profitability, TNON's ROE is -5.47%, compared to PACB's ROE of -49.62%. Regarding short-term risk, TNON is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for TNON.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
TNON vs SENS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SENS has a market cap of 364M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SENS trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SENS's P/E ratio is -3.91. In terms of profitability, TNON's ROE is -5.47%, compared to SENS's ROE of -1.66%. Regarding short-term risk, TNON is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
TNON vs OFIX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, OFIX has a market cap of 361M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while OFIX trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas OFIX's P/E ratio is -5.82. In terms of profitability, TNON's ROE is -5.47%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, TNON is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
TNON vs CV Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CV has a market cap of 329.8M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CV trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CV's P/E ratio is -10.48. In terms of profitability, TNON's ROE is -5.47%, compared to CV's ROE of -1.78%. Regarding short-term risk, TNON is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CV's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
TNON vs CATX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, CATX has a market cap of 321M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while CATX trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas CATX's P/E ratio is -2.12. In terms of profitability, TNON's ROE is -5.47%, compared to CATX's ROE of -0.42%. Regarding short-term risk, TNON is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
TNON vs SMLR Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas SMLR's P/E ratio is 3.92. In terms of profitability, TNON's ROE is -5.47%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, TNON is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for TNON.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
TNON vs TMCI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas TMCI's P/E ratio is -4.80. In terms of profitability, TNON's ROE is -5.47%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, TNON is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check TMCI's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
TNON vs TLSI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, TLSI has a market cap of 287.2M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while TLSI trades at $4.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas TLSI's P/E ratio is -2.78. In terms of profitability, TNON's ROE is -5.47%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, TNON is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check TLSI's competition here
RxSight, Inc. (NASDAQ: RXST)
TNON vs RXST Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, RXST has a market cap of 249.2M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while RXST trades at $6.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas RXST's P/E ratio is -5.33. In terms of profitability, TNON's ROE is -5.47%, compared to RXST's ROE of -0.17%. Regarding short-term risk, TNON is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for TNON.Check RXST's competition here
Avita Medical Inc. (NASDAQ: RCEL)
TNON vs RCEL Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, RCEL has a market cap of 245.4M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while RCEL trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas RCEL's P/E ratio is -6.86. In terms of profitability, TNON's ROE is -5.47%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, TNON is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for TNON.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
TNON vs INFU Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, INFU has a market cap of 245.2M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while INFU trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas INFU's P/E ratio is 29.63. In terms of profitability, TNON's ROE is -5.47%, compared to INFU's ROE of +0.15%. Regarding short-term risk, TNON is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for TNON.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
TNON vs MGRM Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas MGRM's P/E ratio is -12.00. In terms of profitability, TNON's ROE is -5.47%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, TNON is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for TNON.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
TNON vs ELMD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ELMD has a market cap of 225.5M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ELMD trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ELMD's P/E ratio is 20.79. In terms of profitability, TNON's ROE is -5.47%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, TNON is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
TNON vs NVRO Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas NVRO's P/E ratio is -1.91. In terms of profitability, TNON's ROE is -5.47%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, TNON is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for TNON.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
TNON vs PROF Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, PROF has a market cap of 216.9M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while PROF trades at $5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas PROF's P/E ratio is -6.09. In terms of profitability, TNON's ROE is -5.47%, compared to PROF's ROE of -0.56%. Regarding short-term risk, TNON is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for TNON.Check PROF's competition here
Neuronetics, Inc. (NASDAQ: STIM)
TNON vs STIM Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, STIM has a market cap of 210.9M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while STIM trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas STIM's P/E ratio is -6.89. In terms of profitability, TNON's ROE is -5.47%, compared to STIM's ROE of -1.51%. Regarding short-term risk, TNON is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for TNON.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
TNON vs BSGM Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas BSGM's P/E ratio is -5.81. In terms of profitability, TNON's ROE is -5.47%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, TNON is more volatile compared to BSGM. This indicates higher risk in terms of short-term price fluctuations for TNON.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
TNON vs MDGS Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas MDGS's P/E ratio is -0.27. In terms of profitability, TNON's ROE is -5.47%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, TNON is more volatile compared to MDGS. This indicates higher risk in terms of short-term price fluctuations for TNON.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
TNON vs QIPT Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas QIPT's P/E ratio is -15.87. In terms of profitability, TNON's ROE is -5.47%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, TNON is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for TNON.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
TNON vs FOCL Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, FOCL has a market cap of 153.7M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while FOCL trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas FOCL's P/E ratio is -3.96. In terms of profitability, TNON's ROE is -5.47%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, TNON is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for TNON.Check FOCL's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
TNON vs LUCD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, LUCD has a market cap of 149.4M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while LUCD trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas LUCD's P/E ratio is -2.12. In terms of profitability, TNON's ROE is -5.47%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, TNON is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check LUCD's competition here
Quantum-Si incorporated (NASDAQ: QSI)
TNON vs QSI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, QSI has a market cap of 148.7M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while QSI trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas QSI's P/E ratio is -1.63. In terms of profitability, TNON's ROE is -5.47%, compared to QSI's ROE of -0.47%. Regarding short-term risk, TNON is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
TNON vs INGN Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, INGN has a market cap of 143.8M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while INGN trades at $5.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas INGN's P/E ratio is -5.84. In terms of profitability, TNON's ROE is -5.47%, compared to INGN's ROE of -0.13%. Regarding short-term risk, TNON is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for TNON.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
TNON vs QTRX Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, QTRX has a market cap of 120.6M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while QTRX trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas QTRX's P/E ratio is -1.01. In terms of profitability, TNON's ROE is -5.47%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, TNON is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for TNON.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
TNON vs ICAD Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ICAD's P/E ratio is -20.37. In terms of profitability, TNON's ROE is -5.47%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, TNON is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
TNON vs HJLI Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas HJLI's P/E ratio is N/A. In terms of profitability, TNON's ROE is -5.47%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, TNON is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for TNON.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
TNON vs ASXC Comparison September 2026
Tenon Medical, Inc. (NASDAQ: TNON) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TNON stands at 2.9M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, TNON is priced at $5.93 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TNON currently has a P/E ratio of -0.13, whereas ASXC's P/E ratio is -1.12. In terms of profitability, TNON's ROE is -5.47%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, TNON is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for TNON.Check ASXC's competition here